Medivation News

Medivation, Inc. today announced that Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path. will join Medivation in the newly-created position of senior vice president of new projects, reporting to Dr.

The analysts wrote, "Medivation has been downgraded by TheStreet Ratings from hold to sell.

The firm set a "buy" rating on the stock. The analysts wrote, "Medivation is scheduled to report Q1:13 earnings after market close today.

Medivation, Inc. today provided a corporate update and reported its financial results for the first quarter ended March 31, 2013.

Good afternoon, everyone, and welcome to Medivation's First Quarter 2013 Financial Results Conference Call.

"We believe that the fourth quarter may be our strongest quarter of the year," said John Johnson, Dendreon Corporation 's chairman, CEO, and president.

Analysts at Benchmark initiated coverage on shares of Merit Medical Systems with a "hold" rating.

Several other analysts have also recently commented on the stock. Analysts at Goldman Sachs initiated coverage on shares of Medivation in a research note to investors on Tuesday.

StockCall.com Provides Stock Research on Dendreon Corp., Sarepta Therapeutics Inc., ACADIA Pharmaceuticals Inc., Cell Therapeutics Inc., and Medivation Inc.

David Hung, M.D., president and chief executive officer, will present at the UBS Global Healthcare Conference on May 20 at 1pm ET at the Grand Hyatt in New York, NY.

Medivation, Inc. today announced that Wendy Yarno has been elected to the Company's Board of Directors.

Enzalutamide recommended for approval in the European Union for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy 1 Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc.

With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! CHERTSEY, England & SAN FRANCISCO, CA-- --Today, Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc.

One of the best ways that investors can try to decide which stocks will make for a good investment is to look at what the pros are doing.

Medivation, Inc. today announced that it will host a live teleconference with management to discuss first quarter 2013 financial results and provide a general business update on May 9, 2013 at 4:30 p.m. Eastern Time.